p53-mediated apoptosis and genomic instability diseases

Acta Oncologica

Volumn 40, Issue 6, 2001, Pages 696-701

  Robles, A I ^a   Harris, C C ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MUTAGENESIS; TUMORS;

GENOMIC INSTABILITY;

DISEASES;

DNA; HELICASE; PROTEIN P53;

APOPTOSIS; CANCER SUSCEPTIBILITY; CELL ACTIVITY; CONFERENCE PAPER; DNA REPLICATION; DNA SEQUENCE; HUMAN; MICROSATELLITE INSTABILITY; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

APOPTOSIS; CELL CYCLE; DNA DAMAGE; DNA HELICASES; DNA REPAIR; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0035190540     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/02841860152619106     Document Type: Conference Paper

References (63)

1. T antigen is bound to a host protein in SV40-transformed cells
2. Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells
3. Cancer. p53, guardian of the genome
4. p53, the cellular gatekeeper for growth and division
5. Regulation of the p53 tumor suppressor protein
6. Signaling to p53: Breaking the MDM2-p53 circuit
7. p53 mutations in human cancers
8. The p53 tumour suppressor gene
9. Molecular epidemiology of human cancer: Contribution of mutation spectra studies of tumor suppressor genes
10. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms
11. Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome
12. Chromosome instability is a predominant trait of fibroblasts from Li-Fraumeni families
13. p53 function and dysfunction
14. The complexity of p53 modulation: Emerging patterns from divergent signals
15. Dial 9-1-1 for p53: Mechanisms of p53 activation by cellular stress
16. SUMO-1 modification activates the transcriptional response of p53
17. Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1
18. mdm2 expression is induced by wild type p53 activity
19. The p21 cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases
20. WAF1, a potential mediator of p53 tumor suppression
21. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen
22. Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen
23. GADD45 induction of a G2/M cell cycle checkpoint
24. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
25. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis
26. A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage
27. Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a
28. A model for p53-induced apoptosis
29. Analysis of p53-regulated gene expression patterns using oligonucleotide arrays
30. COOH-terminal domain of p53 modulates p53-mediated transcriptional transactivation, cell growth, and apoptosis
31. p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes
32. Induction of apoptosis in HeLa cells by transactivation-deficient p53
33. The XPB and XPD helicases are components of the p53-mediated apoptosis pathway
34. The p53 pathway
35. Wild-type, but not mutant, human p53 proteins inhibit the replication activities of simian virus 40 large tumor antigen
36. DNA helicases in inherited human disorders
37. Nucleotide excision repair and human syndromes
38. A presumed DNA helicase encoded by ERCC-3 is involved in the human repair disorders xeroderma pigmentosum and Cockayne's syndrome
39. Correction of xeroderma pigmentosum complementation group D mutant cell phenotypes by chromosome and gene transfer: Involvement of the human ERCC2 DNA repair gene
40. Mammalian DNA nucleotide excision repair reconstituted with purified protein components
41. Activation of p53 or loss of the Cockayne syndrome group B repair protein causes metaphase fragility of human U1, U2, and 5S genes
42. p53 modulation of TFIIH-associated nucleotide excision repair activity
43. Functional interactions between p53 and the TFIIH complex are affected by tumour-associated mutations
44. Li-Fraumeni syndrome fibroblasts homozygous for p53 mutations are deficient in global DNA repair but exhibit normal transcription-coupled repair and enhanced UV-resistance
45. Expression of wild-type p53 is required for efficient global genomic nucleotide excision repair in UV-irradiated human fibroblasts
46. Direct involvement of p53 in the base excision repair pathway of the DNA repair machinery
47. Ref-1 regulates the transactivation and pro-apoptotic functions of p53 in vivo
48. Drug-induced apoptosis is delayed and reduced in XPD lymphoblastoid cell lines: Possible role of TFIIH in p53-mediated apoptotic cell death
49. Mutations in XPB and XPD helicases found in xeroderma pigmentosum patients impair the transcription function of TFIIH
50. Distinct roles for the helicases of TFIIH in transcript initiation and promoter escape
51. TFIIH with inactive XPD helicase functions in transcription initiation but is defective in DNA repair
52. Rothmund-Thomson syndrome due to RECQ4 helicase mutations: Report and clinical and molecular comparisons with Bloom syndrome and Werner syndrome
53. p53-mediated apoptosis is attenuated in Werner syndrome cells
54. Physical and functional interaction between p53 and the Werner's syndrome protein
55. Werner syndrome and biological ageing: A molecular genetic hypothesis
56. A biomarker that identifies senescent human cells in culture and in aging skin in vivo
57. Absence of radiation-induced G1 arrest in two closely related human lymphoblast cell lines that differ in p53 status
58. A role for PML and the nuclear body in genomic stability
59. Nuclear structure in normal and Bloom syndrome cells
60. Structure, organization, and dynamics of promyelocytic leukemia protein nuclear bodies
61. PML regulates p53 acetylation and premature senescence induced by oncogenic Ras
62. PML is essential for multiple apoptotic pathways
63. PML induces a novel caspase-independent death process